title: ISPD Cardiovascular and Metabolic Guidelines in Adult Peritoneal Dialysis Patients Part II - Management of Various Cardiovascular Complications.
abstract: Cardiovascular mortality has remained high in patients on peritoneal dialysis (PD) due to the high prevalence of various cardiovascular complications including coronary artery disease, left ventricular hypertrophy and dysfunction, heart failure, arrhythmia (especially atrial fibrillation), cerebrovascular disease, and peripheral arterial disease. In addition, nearly a quarter of PD patients develop sudden cardiac death as the terminal life event. Thus, it is essential to identify effective treatment that may lower cardiovascular mortality and improve survival of PD patients. The International Society for Peritoneal Dialysis (ISPD) commissioned a global workgroup in 2012 to formulate a series of recommendation statements regarding lifestyle modification, assessment and management of various cardiovascular risk factors, and management of the various cardiovascular complications to be published in 2 guideline documents. This publication forms the second part of the guideline documents and includes recommendation statements on the management of various cardiovascular complications in adult chronic PD patients. The documents are intended to serve as a global clinical practice guideline for clinicians who look after PD patients. We also define areas where evidence is clearly deficient and make suggestions for future research in each specific area.
authors.affiliation: Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong aymwang@hkucc.hku.hk.
authors.forename: Angela Yee Moon
authors.initials: AY
authors.lastname: Wang
authors.affiliation: St. Joseph's Healthcare, McMaster University, Hamilton, Ontario, Canada.
authors.forename: K Scott
authors.initials: KS
authors.lastname: Brimble
authors.affiliation: Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, Toronto, Ontario, Canada.
authors.forename: Gillian
authors.initials: G
authors.lastname: Brunier
authors.affiliation: Division of Nephrology, The Royal Melbourne Hospital, University of Melbourne, Melbourne, Australia.
authors.forename: Stephen G
authors.initials: SG
authors.lastname: Holt
authors.affiliation: George Institute for Global Health India, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
authors.forename: Vivekanand
authors.initials: V
authors.lastname: Jha
authors.affiliation: University of Queensland at Princess Alexandra Hospital, Brisbane, Australia Centre for Kidney Disease Research, Translational Research Institute, Brisbane, Australia.
authors.forename: David W
authors.initials: DW
authors.lastname: Johnson
authors.affiliation: Department of Internal Medicine, College of Medicine, Severance Biomedical Science Institute, Yonsei University, Korea.
authors.forename: Shin-Wook
authors.initials: SW
authors.lastname: Kang
authors.affiliation: Division of Nephrology, University Hospital Maastricht, Maastricht, The Netherlands.
authors.forename: Jeroen P
authors.initials: JP
authors.lastname: Kooman
authors.affiliation: Health Services Research Unit, Institute for Science and Technology in Medicine, Keele University, Keele, Staffordshire, United Kingdom.
authors.forename: Mark
authors.initials: M
authors.lastname: Lambie
authors.affiliation: School of Medicine, University of Nottingham, Royal Derby Hospital Centre, Derby, United Kingdom.
authors.forename: Chris
authors.initials: C
authors.lastname: McIntyre
authors.affiliation: Harborview Medical Center, Division of Nephrology/Department of Medicine, University of Washington, Washington, DC, United States.
authors.forename: Rajnish
authors.initials: R
authors.lastname: Mehrotra
authors.affiliation: School of Medicine, Pontifícia Universidade Católica do Paraná, Curitiba, Paraná, Brazil.
authors.forename: Roberto
authors.initials: R
authors.lastname: Pecoits-Filho
mesh_terms: D001281:Atrial Fibrillation / Q000209:etiology / Q000401:mortality; D002318:Cardiovascular Diseases / Q000209:etiology* / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D003324:Coronary Artery Disease / Q000209:etiology / Q000401:mortality; D005260:Female; D006333:Heart Failure / Q000209:etiology / Q000401:mortality; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000209:etiology / Q000401:mortality; D008297:Male; D010530:Peritoneal Dialysis / Q000009:adverse effects* / Q000592:standards; D017410:Practice Guidelines as Topic; D011379:Prognosis; D012955:Societies, Medical; D020521:Stroke / Q000209:etiology / Q000401:mortality; D016019:Survival Analysis
keywords: Coronary artery disease; atrial fibrillation; heart failure; left ventricular hypertrophy; peripheral artery disease; peritoneal dialysis; stroke; sudden cardiac death